News
Takotsubo Syndrome and the Brain-Heart Connection: Frederic Schaper, MD, PhD
Published: April 19th 2024 | Updated: May 20th 2024The instructor in neurology at Brigham and Women's Hospital talked about research exploring takotsubo syndrome, a heart condition often triggered by emotional or physical stressors, and its relationship with brain lesions. [WATCH TIME: 5 minutes]
The AI Revolution That Could Slow Parkinson In Its Tracks
April 19th 2024Neal K. Shah, CEO of CareYaya Health Technologies, an AI innovator in neurological care, discussed how technology is poised to transform the fight against Parkinson, with the potential to improve millions of lives and advance health equity.
Impact of Antiepileptic Medications and Sex Hormones on Maternal and Child Outcomes in Epilepsy
April 18th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
A Promising New Approach To Reduce Repeat Surgeries for Subdural Hematomas: Jason M. Davies, MD, PhD
Published: April 18th 2024 | Updated: May 2nd 2024The assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo talked about the potential of embolizing the middle meningeal artery in patients with subdural hematomas. [WATCH TIME: 4 minutes]
Integrative and Alternative Patient-Centered Therapies in Neurology: Carolyn Bernstein, MD
April 17th 2024The assistant professor of neurology at Harvard Medical School talked about integrative therapies that may offer promising alternatives to traditional treatments for aiding neurological conditions. [WATCH TIME: 5 minutes]
Analysis on the Efficacy of Cenobamate in Pediatric Patients With Refractory Epilepsy
April 17th 2024Kate Labiner, MD, a pediatric epileptologist at Child Neurology Consultants of Austin, talked about the potential of cenobamate in pediatric patients with refractory focal epilepsy who have failed multiple medications.
Safety of Cancer Treatments in Patients With Multiple Sclerosis: Prashanth Rajarajan, MD, PhD
April 17th 2024The neurology resident at Massachusetts General Brigham talked about assessing the safety of cancer treatments in patients with multiple sclerosis using checkpoint inhibitors. [WATCH TIME: 6 minutes]
Pregnancy Outcomes of Maternal Exposure to Ocrelizumab: Riley Bove, MD
April 16th 2024The associate professor of neurology at University of California, San Francisco talked about findings from an analysis that assessed the safety of ocrelizumab when administered close to pregnancy. [WATCH TIME: 5 minutes]
Improvements in Alzheimer Agitation, Response Rates Seen Through Brexpiprazole
April 15th 2024Over 2, phase 3 studies, brexpiprazole-treated patients demonstrated greater response rates across various levels on the Cohen-Mansfield Agitation Index and Clinical Impression Scale-Improvement assessment.
Recognizing Excellence in Multiple Sclerosis Research, the Dystel Prize: Bruce Bebo, PhD
April 15th 2024The executive vice president of research at National MS Society talked about the Dystel Prize which is presented at AAN to a recognized individual who promotes further advancements in understanding and treating MS. [WATCH TIME: 3 minutes]
Understanding Headache Essentials for General Neurologists: Susan W. Broner, MD
April 15th 2024The medical director of the Weill Cornell Medicine Headache Program discussed key essential knowledge on the diagnosis, treatment, and pathophysiology of different headache types. [WATCH TIME: 6 minutes]
Cenobamate's Efficacy in Drug-Resistant Epilepsy: Jacob Pellinen, MD
April 14th 2024The assistant professor of neurology at University of Colorado School of Medicine discussed findings on the impact of cenobamate on hospital visits and emergency care for patients with drug-resistant epilepsy following surgery. [WATCH TIME: 3 minutes]
New Insights into BTK Inhibitors and MRI Techniques for Smoldering MS: Thomas F. Scott, MD
April 14th 2024The director of the Allegheny Multiple Sclerosis Treatment Center at Allegheny General Hospital discussed exploring the potential role of BTK inhibitors and advanced MRI techniques to address smoldering multiple sclerosis. [WATCH TIME: 10 minutes]
